Hot Pursuit     28-May-15
AstraZeneca Pharma jumps after turnaround Q4 result
AstraZeneca Pharma India gained 12.41% to Rs 964.50 at 09:50 IST on BSE after the company reported net profit of Rs 38.13 crore in Q4 March 2015 as against net loss of Rs 2.57 crore in Q4 March 2014.

The result was announced after market hours yesterday, 27 May 2015.

Meanwhile, the S&P BSE Sensex was up 23.38 points or 0.08% at 27,588.04

On BSE, so far 28,511 shares were traded in the counter as against average daily volume of 5,562 shares in the past one quarter.

The stock hit a high of Rs 1,009.75 and a low of Rs 952.75 so far during the day. The stock had hit a 52-week low of Rs 785.30 on 17 December 2014. The stock had hit a 52-week high of Rs 1,245 on 23 June 2014.

The small-cap company has equity capital of Rs 5 crore. Face value per share is Rs 2.

AstraZeneca Pharma India's total income rose 31.2% to Rs 169.90 crore in Q4 March 2015 over Q4 March 2014.

AstraZeneca Pharma India is one of the leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare. The company is involved in both manufacturing and marketing of medicines.

Previous News
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 27-Jun-22   17:01 )
  AstraZeneca Pharma slumps after Q3 PAT slides 46% YoY to Rs 16 cr
 ( Hot Pursuit - 09-Feb-24   10:32 )
  Astrazeneca Pharma gains after CDSCO nod to sale Tremelimumab solution
 ( Hot Pursuit - 02-Jun-23   10:05 )
  AstraZeneca Pharma hits 52 week high after Q1 PAT soars to Rs 54 cr
 ( Hot Pursuit - 14-Aug-23   16:04 )
  Astrazeneca Pharma gains after DGCA approves anti-diabetic drug
 ( Hot Pursuit - 26-Sep-19   10:25 )
  Astrazeneca Pharma India standalone net profit rises 204.97% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:13 )
  AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets
 ( Hot Pursuit - 28-Nov-22   10:12 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 04-Aug-20   10:39 )
  AstraZeneca receives DCGI approval for launch of Olaparib Film-Coated tablets in India
 ( Corporate News - 19-Aug-22   19:06 )
  Astrazeneca Pharma India reports standalone net loss of Rs 27.96 crore in the September 2014 quarter
 ( Results - Announcements 04-Nov-14   08:42 )
  Astrazeneca Pharma India standalone net profit rises 60.84% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   07:33 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top